COMMITTEE OF ORIGIN: Standing Committee on Emerging Issues
Currently, a health care provider must not knowingly prescribe or administer cross-sex hormones or puberty-blocking drugs for the purpose of a gender transition for any individual under 18 years of age.
This bill repeals the expiration date for the prohibition.
This bill specifies that, after March 1, 2027, prescriptions for cross-sex hormones or puberty-blocking drugs that were given to individuals under 18 years old for the purpose of assisting the individual with a gender transition prior to August 28, 2023, will no longer be considered valid.
This bill is similar to HB 1038 (2025).
Statutes affected: